Outcomes graft survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Transplants Antilymphocyte Serum Kidney Allografts Saphenous Vein Veins Portal Vein T-Lymphocytes Endothelium, Corneal Cornea Hepatic Artery Cells, Cultured Spleen Ear Auricle Femoral Artery Liver Jugular Veins CD4-Positive T-Lymphocytes Cell Line, Tumor T-Lymphocytes, Regulatory Islets of Langerhans Popliteal Artery

Organisms9

Rats, Inbred Lew Mice, Inbred C57BL Mice, Inbred BALB C Rats, Inbred WF Mice, Knockout Mice, Inbred C3H Mice, Transgenic Mice, Inbred Strains Rats, Inbred BN

Diseases44

Cadaver Graft Occlusion, Vascular Postoperative Complications Delayed Graft Function Brain Death Liver Failure Kidney Failure, Chronic Recurrence Death Primary Graft Dysfunction Acute Disease Corneal Neovascularization Kidney Diseases Disease Progression Disease Models, Animal Corneal Edema Blood Group Incompatibility Liver Diseases Graft vs Host Disease Chronic Disease Ischemia Corneal Endothelial Cell Loss Biliary Tract Diseases Hepatitis C Neoplasm Recurrence, Local Corneal Diseases Thrombosis Diabetes Mellitus, Type 1 Breast Neoplasms Lung Neoplasms Renal Insufficiency Constriction, Pathologic Fuchs' Endothelial Dystrophy Keratoconus Adenocarcinoma Infection Prosthesis-Related Infections Neoplasm Metastasis Biliary Atresia Proteinuria Reperfusion Injury Liver Neoplasms Neoplasms Aortic Aneurysm, Abdominal

Chemicals and Drugs39

Immunosuppressive Agents Tacrolimus Cyclosporine Mycophenolic Acid Antilymphocyte Serum Azathioprine HLA Antigens Isoantibodies Polytetrafluoroethylene Organ Preservation Solutions Creatinine Antibodies, Monoclonal Complement C4b Raffinose Isoantigens Immunoconjugates Sirolimus Polyethylene Terephthalates Prednisone Calcineurin Cyclosporins ABO Blood-Group System Biological Markers CD40 Ligand Procaine Steroids Antineoplastic Agents Tumor Markers, Biological Adrenal Cortex Hormones Antibodies, Monoclonal, Humanized Methylprednisolone Propylene Glycols Allopurinol Cytokines Antibodies Mannitol Antigens, CD RNA, Messenger HLA-B Antigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment107

Kidney Transplantation Treatment Outcome Survival Rate Retrospective Studies Liver Transplantation Survival Analysis Transplantation, Homologous Follow-Up Studies Pancreas Transplantation Corneal Transplantation Heart Transplantation Keratoplasty, Penetrating Histocompatibility Testing Kaplan-Meier Estimate Disease-Free Survival Immunosuppression Skin Transplantation Cold Ischemia Islets of Langerhans Transplantation Risk Factors Organ Preservation Reoperation Proportional Hazards Models Prospective Studies Prognosis Pregnancy Outcome Transplantation, Heterotopic Graft Enhancement, Immunologic Blood Vessel Prosthesis Multivariate Analysis Cohort Studies Risk Assessment Donor Selection Predictive Value of Tests Incidence Anastomosis, Surgical Transplantation Biopsy Tissue and Organ Harvesting Drug Therapy, Combination Registries Transplantation, Isogeneic Severity of Illness Index Neoplasm Staging Blood Vessel Prosthesis Implantation Patient Selection Actuarial Analysis Treatment Failure Combined Modality Therapy Fetal Tissue Transplantation Organ Transplantation Immunohistochemistry Chi-Square Distribution Renal Dialysis Coronary Artery Bypass Postoperative Period Transplantation, Heterologous Antineoplastic Combined Chemotherapy Protocols Descemet Stripping Endothelial Keratoplasty Brain Tissue Transplantation Probability Disease Models, Animal Postoperative Care Logistic Models Lymphocyte Culture Test, Mixed Kidney Function Tests Transplantation, Autologous Prosthesis Design Models, Animal Warm Ischemia Bone Marrow Transplantation Lung Transplantation Preoperative Care Blood Transfusion Glomerular Filtration Rate Length of Stay Randomized Controlled Trials as Topic Plasmapheresis Nephrectomy Regression Analysis Analysis of Variance Cause of Death Arteriovenous Shunt, Surgical Cryopreservation Administration, Ophthalmic Stents Life Tables Clinical Trials as Topic Statistics, Nonparametric Risk Tomography, X-Ray Computed Case-Control Studies Vascular Surgical Procedures Odds Ratio Cell Transplantation Lymphocyte Transfusion Reconstructive Surgical Procedures Blood Grouping and Crossmatching Drug Administration Schedule Hospital Mortality Reproducibility of Results Hepatectomy Reverse Transcriptase Polymerase Chain Reaction Chemotherapy, Adjuvant Double-Blind Method Liver Function Tests Glasgow Outcome Scale

Phenomena and Processes23

Graft Survival Graft Rejection Cell Survival Time Factors Transplantation Tolerance Pregnancy Outcome Transplantation Immunology Histocompatibility Vascular Patency Chi-Square Distribution Apoptosis Probability Pregnancy Glomerular Filtration Rate Immune Tolerance Signal Transduction Cell Proliferation Risk Odds Ratio Recovery of Function Dose-Response Relationship, Drug Lymphangiogenesis Genotype

Disciplines and Occupations2

Outcome Assessment (Health Care)Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Technology, Industry, Agriculture2

Polytetrafluoroethylene Polyethylene Terephthalates

Humanities1

Quality of Life

Information Science8

Survival Rate Incidence Registries Databases as Topic Cause of Death Life Tables Hospital Mortality Glasgow Outcome Scale

Named Groups5

Tissue Donors Living Donors Infant, Newborn Continental Population Groups African Continental Ancestry Group

Health Care48

Treatment Outcome Survival Rate Retrospective Studies Survival Analysis Follow-Up Studies Tissue and Organ Procurement Outcome Assessment (Health Care)Kaplan-Meier Estimate Disease-Free Survival Risk Factors Proportional Hazards Models Prospective Studies Multivariate Analysis Cohort Studies Risk Assessment Age Factors Donor Selection Predictive Value of Tests Incidence Registries Severity of Illness Index Patient Selection Waiting Lists Actuarial Analysis Treatment Failure Outcome and Process Assessment (Health Care)Chi-Square Distribution Postoperative Period Probability Postoperative Care Logistic Models Preoperative Care Length of Stay Randomized Controlled Trials as Topic Regression Analysis Analysis of Variance Cause of Death Life Tables Clinical Trials as Topic Statistics, Nonparametric Risk Sex Factors Case-Control Studies Odds Ratio Hospital Mortality Reproducibility of Results Double-Blind Method Glasgow Outcome Scale

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Graft Survival Kidney Transplantation Graft Rejection Treatment Outcome Survival Rate Tissue Donors Cell Survival Immunosuppressive Agents Retrospective Studies Liver Transplantation Time Factors Cadaver Survival Analysis Transplantation, Homologous Follow-Up Studies Living Donors Graft Occlusion, Vascular Pancreas Transplantation Corneal Transplantation Heart Transplantation Keratoplasty, Penetrating Tissue and Organ Procurement Postoperative Complications Outcome Assessment (Health Care)Histocompatibility Testing Tacrolimus Kaplan-Meier Estimate Disease-Free Survival Immunosuppression Cyclosporine Skin Transplantation Delayed Graft Function Cold Ischemia Islets of Langerhans Transplantation Survival Risk Factors Organ Preservation Mycophenolic Acid Reoperation Proportional Hazards Models Prospective Studies Brain Death Transplants Prognosis Transplantation Tolerance Pregnancy Outcome Transplantation, Heterotopic Liver Failure Graft Enhancement, Immunologic Blood Vessel Prosthesis Kidney Failure, Chronic Multivariate Analysis Recurrence Death Cohort Studies Primary Graft Dysfunction Antilymphocyte Serum Transplantation Immunology Azathioprine HLA Antigens Rats, Inbred Lew Isoantibodies Mice, Inbred C57BL Risk Assessment Age Factors Polytetrafluoroethylene Organ Preservation Solutions Kidney Mice, Inbred BALB C Donor Selection Predictive Value of Tests Incidence Anastomosis, Surgical Creatinine Transplantation Biopsy Acute Disease Histocompatibility Tissue and Organ Harvesting Vascular Patency Drug Therapy, Combination Registries Transplantation, Isogeneic Corneal Neovascularization Severity of Illness Index United States Antibodies, Monoclonal Neoplasm Staging Blood Vessel Prosthesis Implantation Patient Selection Complement C4b Waiting Lists Actuarial Analysis Infant, Newborn Raffinose Treatment Failure Outcome and Process Assessment (Health Care)Combined Modality Therapy Isoantigens Immunoconjugates

No FAQ available that match "outcomes graft survival"